Abstract Chromatin immunoprecipitation (ChIP) assays allow the efficient characterization of the in vivo occupancy of genomic regions by DNA-binding proteins and thus facilitate the prediction of cis-regulatory sequences in silico and guide their validation in vivo. For these reasons, these assays and their permutations (e.g., ChIP-on-chip and ChIP-sequencing) are currently being extended to several non-mainstream model organisms, as the availability of specific antibodies increases. Here, we describe the development of a polyclonal antibody against the Brachyury protein of the marine invertebrate chordate Ciona intestinalis and provide a detailed ChIP protocol that should be easily adaptable to other marine organisms.
Introduction
After serving as the model organisms of choice for embryological studies for well over a century (Chabry 1887; Conklin 1905) , ascidians have rapidly entered their post-genomic era after the genomes of Ciona intestinalis and Ciona savignyi were fully sequenced (Dehal et al. 2002; Vinson et al. 2005) . Currently, there is a growing interest in studying the in vivo occupancy of genomic sequences that might work as enhancers, or cis-regulatory modules (CRMs), by transcription factors, both at the level of individual Ciona CRMs (e.g., Kanda et al. 2009; Dunn and Di Gregorio 2009 ) or on a genome-wide scale (Kubo et al. 2010) . Such studies, which mainly rely upon chromatin immunoprecipitation (ChIP), are instrumental for the reconstruction of the gene regulatory networks controlling the development of these simple chordates, and are informative for more complex organisms in this phylum (Delsuc et al. 2006; Davidson and Christiaen 2006; Lemaire 2009 ). For these reasons, we have optimized in C. intestinalis the following ChIP protocol, which should provide a useful reference for similar assays in other ascidian species and in related marine embryos. The method is used here in combination with a polyclonal antibody that was raised against the Ciona Brachyury (Ci-Bra) protein.
Materials and Methods

Animal Husbandry and Embryo Culturing
Adult C. intestinalis (species A; Caputi et al. 2007) were purchased from Marine Research and Educational Products (Carlsbad, CA) and maintained in a refrigerated aquarium with recirculating artificial seawater at a temperature of 18°C. Detailed protocols describing fertilization, dechorionation, and culturing of Ciona embryos have been published previously (Zeller 2004; Christiaen et al. 2009 ). Dechorionated C. intestinalis embryos were grown in Petri dishes in filtered artificial seawater (FSW) until the desired stage(s) was reached, usually at temperatures ranging from 15 to 21°C (Whittaker 1977 ).
Generation of a Ciona Brachyury Polyclonal Antibody
The full-length 1,324-bp Ci-Bra cDNA (NCBI accession no. NM_001032487; Corbo et al. 1997 ) was PCR amplified using as a template RNA extracted from mid-tailbud embryos, as previously described (Oda-Ishii and Di Gregorio 2007) , was cloned first into the pGEM-T vector (Promega, Madison, WI, USA), and then transferred to the BglII and EcoRI sites of the pRSET-B vector (Invitrogen, Carlsbad, CA, USA) in frame with a Histidine tag. The His-Ci-Bra protein was induced in bacteria at 25°C using 0.5 mM IPTG and purified essentially as previously published (Gazdoiu et al. 2005) . The purified protein was run on a 10 % sodium dodecyl sulfate (SDS)-PAGE gel and stained with Coomassie blue (Bio-Rad, Hercules, CA, USA).
The size of the purified tagged protein was~53.5 kDa, as predicted (data not shown). Approximately 2 mg were sent to Covance, Inc. (Princeton, NJ, USA) for the generation of polyclonal antibodies in rabbits.
In parallel, we also generated a GST-Ci-Bra protein by cloning the sequence encoding the C-terminal half of the Ci-Bra protein in the pGEX2T vector. We used this protein to purify the anti-His-Bra antibody from the immune sera by attaching it covalently to agarose-glutathione beads, using the GST Orientation kit (Thermo Scientific, Rockford, IL, USA). The affinity resin that was reacted with the immune sera was washed twice with 0.5 M KCl-HEG buffer (0.5 M KCl, 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-KOH pH 7.5, 0.5 mM EDTA pH 8.0, 0.1 % NP-40, 10 % glycerol), then extensively washed with wash buffer (20 mM Tris-HCl pH 7.5, 1 M NaCl, 1 % Triton X-100). The antibody was eluted by adding elution buffer (0.2 M glycine pH 2.2, 0.5 M NaCl), and the eluate was rapidly neutralized with 1 M Tris-HCl, pH 8.0. The purified antibody was concentrated by ammonium sulfate precipitation and subsequently dialyzed against 50 mM KCl-HEG overnight, then quantified against bovine serum albumin (BSA) standards using a spectrophotometer.
Immunohistochemistry
Dechorionated C. intestinalis embryos were fixed at room temperature for 50 min in 4 % paraformaldehyde/phosphatebuffered saline (PBS), washed twice in PBS for 5 min, then washed for 20 min in 0.25 % Triton X-100, 0.1 % Tween-20 in PBS, and washed again once in PBS before being incubated overnight in PBS/1 % BSA at 4°C in the presence of the CiBra-specific antibody, as described in Zega et al. (2008) . After a series of washes in PBS, the embryos were incubated overnight at 4°C, in the dark and with gentle rocking, with a goat anti-rabbit Alexa Fluor 546 fluorescent secondary antibody in PBS (Invitrogen, Carlsbad, CA, USA). The following day, the embryos were washed five to six times in PBS for a total of~1 h, mounted with mounting medium containing 4′,6-diamidino-2-phenylindole (DAPI) (Vectashield; Vector Laboratories, Burlingame, CA, USA), and photographed using a Leica DMR fluorescent microscope.
Chromatin Immunoprecipitation
This method has been adapted to Ciona embryos using previously published protocols as a reference (Lee et al. 2006; Nelson et al. 2006) . The ChIP protocol detailed here has been used for embryos at the mid-tailbud stage, grown at 15°C for 15 h, and has been employed successfully on both wild-type and transgenic embryos. For reference, a 100-mm-diameter Petri dish containing 25 mL FSW holds about 5,000 embryos and provides a~25-μL pellet, corresponding to roughly 10 7 cells.
Cross-Linking
Embryos were fixed for 10 min at room temperature on a rotating platform after adding fresh formaldehyde (Polysciences, Warrington, PA, USA) to a final concentration of 1 % to the Petri dishes. After cross-linking was quenched with 2.5 M glycine for 5 min, embryos were transferred to fresh Petri dishes containing PBS pH 7.4 (Life Technologies, catalog no. 10010-023) and washed for 10 min with gentle rotation, then transferred to 1.5-mL microfuge tubes, collected by brief centrifugation, and washed once more in PBS. Note that at this point, after carefully removing as much PBS as possible, embryos can be stored at −80°C as a pellet, if necessary.
Chromatin Fragmentation
To fractionate chromatin, approximately 100 μL of fixed embryos (i.e.,~20,000 embryos, collected from four 100-mm Petri dishes) were sonicated in a final volume of 1 mL in IP buffer (Table 1) containing a protease inhibitor cocktail (Roche Applied Science, no. 1873580).
Note that as an alternative to the pre-made cocktail, we also used successfully a combination of protease inhibitors containing, per milliliter, 2.5 μL of 200 mM PMSF (final concentration 0.5 mM), 1 μL of 10 μg/μL leupeptin (final concentration 10 μg/mL), and 1 μL of 10 μg/μL aprotinin (final concentration 10 μg/mL).
Sonication was carried out on ice in a 1.5-mL microfuge tube, 20 times for 12 s each, using a Branson 250 sonicator at a power setting of 4 and 30 % duty cycle.
Note that sonication is a key step in this protocol. The optimal conditions required to obtain the desired fragment size may vary depending upon the sonicator employed and should be determined by monitoring the fragmentation achieved using different conditions (e.g., 14, 16, 18 times, etc.). As an alternative to sonication, the chromatin can be digested with micrococcal nuclease (Gaffney et al. 2012 ).
Reverse Cross-Linking and DNA Purification of the Input Sample
After sonication, 30 μL of the sonicated sample [whole cell extract (WCE)] were transferred to a 2-mL microfuge tube for reverse cross-linking to be used as the WCE input sample, while the remainder (970 μL) was stored at −80°C. The WCE input sample was first mixed with 210 μL of DNase-free water and 60 μg of RNase A (from a 10 mg/mL stock) and incubated at 37°C for 30 min to remove RNA that might interfere with the visualization of short DNA fragments on agarose gel. The chromatin was then reverse cross-linked by incubating overnight at 65°C in the presence of 30 μg of proteinase K (from a 10 mg/mL stock), 125 mM NaHCO 3 , and 1.25 % SDS. After addition of 1.5 mL PB buffer (Qiagen, Valencia, CA, USA; catalog no. 27104), the sample was incubated for 1 h at room temperature on a nutator, then purified using the QIAprep Spin Miniprep columns (Qiagen). The WCE input sample was applied to a column, then centrifuged at 13,200 rpm for 1 min. The column was then washed first with 0.6 mL of PB buffer and subsequently with 0.75 mL of PE buffer (Qiagen), followed by centrifugation as described above. The purified DNA was subsequently eluted by incubating twice with 50 μL of Elution Buffer (Qiagen) for 10 min, followed by centrifugation at 13,200 rpm for 1 min. Ten microliters of the purified WCE input was used to check the DNA fragmentation, while the remaining amount was stored at −20°C, to be used later for quantitative PCR (qPCR). The size of the DNA fragments was assessed by electrophoresis using a 1.5 % agarose gel and staining with ethidium bromide to a final concentration of 0.5 μg/mL. If the fragment size was found to range between 200 and 800 bp, then the 970-μL WCE sample(s), previously stored at −80°C, was used for immunoprecipitation.
Immunoprecipitation
For the immunoprecipitation, 50 μL of Dynabeads Protein A (Invitrogen, Carlsbad, CA, USA) were pretreated by washing with 950 μL IP buffer (Table 1) , and then by incubating with 950 μL of IP buffer containing 1 mg BSA and 2 μg sonicated salmon sperm DNA for 3 h at 4°C with rotation.
Note that salmon sperm DNA or other carrier DNAs should not be used in the blocking solution if ChIP-Seq experiments are planned, in order to avoid contamination in the sequencing steps.
After the 3-h incubation, the beads were separated from the IP buffer using the Dynal magnetic rack (Invitrogen), according to the manufacturer's instructions, then quickly washed twice with fresh IP buffer at 4°C.
The 970-μL WCE samples were thawed on ice, then centrifuged at 13,200 rpm for 15 min at 4°C, and the supernatant was transferred to fresh microfuge tubes. For preclearing nonspecific background, the samples were incubated with 50 μL of the pretreated beads and 0.5 μg normal rabbit IgG (Jackson ImmunoResearch, West Grove, PA, USA) for 6 h at 4°C on a nutator.
Note that after the first 3 h of incubation, pretreatment of two additional 50-μL aliquots of beads in 1.5-mL microfuge tubes should begin, as described above.
After preclearing, the WCE samples were separated from the beads using the magnetic rack, and the beads were discarded. Precleared WCE samples were then divided equally into the two tubes containing the 50-μL aliquots of pretreated beads and incubated overnight at 4°C on a nutator with 0.25 μg of normal rabbit IgG and the specific antibody of choice, respectively. Note that the beads should not be allowed to dry out; for this reason, we recommend removing the IP buffer just before adding the precleared WCE samples to the beads.
We have used this protocol with the His-Ci-Bra antibody on wild-type embryos (Fig. 1) , and with green fluorescent protein (GFP) antibodies on transgenic embryos carrying the Ci-Bra>Ci-Bra/GFP transgene (data not shown).
Note that to minimize background signal, we recommend purifying the antibody (e.g., as described above).
Dynabeads bound to the immunoprecipitated DNA were then washed five times for 10 min on a nutator at 4°C with 1.5 mL of ice-cold radioimmunoprecipitation assay (RIPA) buffer (Table 1) , followed by two 2-min washes with 1.5 mL of ice-cold Tris-EDTA (TE) buffer (Table 1) . After transferring the tubes to the magnetic rack, the supernatant was carefully aspirated, and the tubes were removed from the rack. Subsequently, the beads were incubated in 300 μL of TE buffer containing 60 μg of RNase A at 37°C for 30 min, then washed again with 1.5 mL of TE buffer.
Note that at this point, most of the supernatant should be carefully removed.
Reverse Cross-Linking and DNA Purification of the Immunoprecipitated Sample
The immunoprecipitated DNA was eluted by incubating twice for 45 min with 150 μL of freshly made bicarbonate/SDS buffer (Table 1) , at room temperature. The eluted sample (300 μL) was reverse cross-linked by addition of 30 μg of proteinase K and overnight incubation at 65°C, purified as described above, then subjected to PCR and/or qPCR in parallel with the WCE input sample.
Note that proteinase K incubation can be shortened to 2 h. Fig. 1 Use of the Ciona Brachyury antibody for immunofluorescence and ChIP assays. a-c C. intestinalis mid-tailbud embryo immunostained with the Ci-Bra antibody. a Counterstaining with DAPI visualizes nuclei. b, c The Ci-Bra antibody specifically stains the nuclei of the 40 notochord cells. d, e Results of ChIP assays on the Ci-tune notochord CRM, as detected by PCR (d) and qPCR (e). In d, lanes were loaded as follows: Lane 1 DNA ladder (1-kb Plus DNA Ladder, Invitrogen, cat no. 10787-018). Lane 2 PCR product (134 bp) obtained from chromatin immunoprecipitated with 50 μg of Ci-Bra antibody (red arrow). Primers: Ci-tune forward 5′-GTGTTGCGTACACACTCAAAGTCAG-3′ and Citune reverse 5′-GCAGGGCAGTTCTGATAAACACGTTGT-3′. Lane 3 negative control; PCR product of Ciona chromatin immunoprecipitated with 50 μg of pre-immune serum. Lane 4 134-bp PCR product obtained by amplifying 10 μL of a 50 % dilution (~200 ng) of the WCE input sample (red arrow). In e, ChIP was performed on two biological replicates, and qPCR was performed on 10 ng of each sample, in triplicate, using SYBR Green in a Prism 7700 Real-Time qPCR thermocycler (ABI, Carlsbad, CA, USA). To obtain standard curves, we used samples containing 20, 2, 0.2, and 0.02 ng/μL of Ciona genomic DNA, each in duplicate. The percent input and standard deviation were calculated from the average of triplicate immunoprecipitated/input WCE scores. One representative biological dataset is shown in the figure. The p value (p<0.001) was calculated using a two-tailed Student's t test
Results and Discussion
Ci-Bra encodes a sequence-specific transcription factor that in Ciona and other ascidians, such as Halocynthia, is specifically expressed in the notochord (Corbo et al. 1997; Yasuo and Satoh 1993) . Brachyury plays a pivotal role in notochord formation in all chordates analyzed so far and is evolutionarily conserved not only across the chordate phylum, but also among other deuterostomes and in protostomes, such as the fruit fly Drosophila, where the Brachyury ortholog, Brachyenteron, is expressed in the hindgut and is required for the morphogenesis of this structure (Singer et al. 1996; Swalla 2006) . In addition to being a major developmental regulator, Brachyury is also a specific marker and a causative agent of chordoma, a notochordderived tumor (Vujovic et al. 2006; Yang et al. 2009 ). For these reasons, the identification of genes targeted by this transcription factor is of particular interest.
We first tried to raise polyclonal antibodies directed against a short synthetic peptide custom designed from the Ci-Bra protein sequence; however, this approach was unsuccessful because the resulting antiserum produced mostly background signal in preliminary tests (data not shown). We then tried the bacterial expression, recovery, and purification of full-length and truncated versions of Ci-Bra, and the most satisfactory results were obtained with the full-length His-tagged Ci-Bra. Figure 1 shows both the results of an immunofluorescence experiment and the detection of ChIP results. The antibody raised against the full-length His-tagged Ci-Bra protein was first tested by immunohistochemistry (Fig. 1a-c) and by western blot (data not shown). The same antibody was then affinity purified (see "Materials and Methods") and used for ChIP assays with primers specifically designed to amplify a 134-bp fragment of the Ci-tune notochord CRM. The Ci-tune notochord CRM is part of a Ciona genomic region that contains two Ci-Bra-binding sites, which we have previously shown to be bound by Ci-Bra via electrophoretic mobility shift assays (Passamaneck et al. 2009 ). Thus, the Ci-tune notochord CRM provided us with a reliable positive control. We obtained similar results when the Ci-tropomyosin-like notochord CRM, another direct Ci-Bra target (Di Gregorio and Levine 1999), was used as a positive control (data not shown). The ChIP results were first visualized by agarose gel electrophoresis followed by ethidium bromide staining (Fig. 1d) . Subsequently, qPCR experiments (Fig. 1e) allowed us to obtain an accurate quantification of the results.
Conclusions
The straightforward protocol provided here and the availability of an ascidian Brachyury antibody pave the way for studies of the genes regulated by this transcription factor in Ciona, and possibly in other ascidian species, and should aid the application of ChIP assays in other marine organisms. In Ciona, numerous early target genes of Ci-Bra have been identified through genome-wide ChIP-chip analyses by employing anti-GFP antibodies on embryos expressing a Ci-Bra/GFP fusion (Kubo et al. 2010 ). This approach has been very successful in early Ciona embryos and has yielded numerous target genes not only for Ci-Bra but also for several other transcription factors (Kubo et al. 2010) . The availability of a specific Ci-Bra antibody now allows the identification of notochord genes controlled by this factor at later developmental stages. In addition, the combination of this specific antibody and of the step-by-step protocol described here facilitates the validation of Ci-Bra occupancy at the level of individual genomic loci of interest, as well as the prediction of late-acting, Ci-Bra-dependent notochord cis-regulatory elements.
